In vivo and ex vivo sonographic evaluation of tumor margins during micrographic‐controlled surgery: a promising new tool in dermato‐oncology?
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15827 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Diana Crisan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, Margins of Excision, Mohs Surgery, Basal Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives The current research examined the In vivo and ex vivo use of high‐frequency ultrasound (HFUS) during micrographic‐controlled surgery (MCS) of non‐melanoma skin cancer (NMSC) of the head‐and‐face area, particularly the perioperative surgical margin assessment for potential reduction in surgical steps and patients’ hospitalization time. Patients and Methods Pre‐operative in vivo and ex vivo sonographies of 136 NMSCs from 111 patients were evaluated retrospectively for tumor margin assessment during MCS by an experienced dermatosurgeon, while the specimens were independently assessed by a histopathologist.
Results
Our ex‐vivo tumor margin assessment showed a specificity of >98% for squamous cell and basal cell carcinoma, with only five false‐negative and two false‐positive results, when compared to histopathology. HFUS correctly identified tumor‐free margins in 89% of investigated lesions after first resection, as well as eight incomplete excisions (6%) in which a re‐excision was performed and tumor residues were detected histologically. Overall, HFUS showed a very high accuracy in detecting both cancer‐free margins and remaining tumor residues.
Conclusions
HFUS is a highly accurate method for rapidly assessing tumor margins during MCS of NMSC of highly esthetic areas, having the potential to significantly reduce surgical steps and hospitalization time in dermatosurgical patients, improving the quality of healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.
- Department of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
- Department of Dermatology, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
- Institute for Diagnostic Imaging and Research of the Skin and Soft Tissues, Santiago, Chile.
- Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, USA.
- Dermatology, Hospital Universitario Puerta De Hierro Majadahonda, Madrid, Spain.
ORCID-Profile: Diana Crisan
Zitieren
APA
Crisan, D., Wortsman, X., Alfageme, F., Scharffetter-Kochanek, K., Crisan, M., Bernhard, L., Tarnowietzki, E., Schneider, L. A., & Schmid-Wendtner, M. H. (2025). In vivo and ex vivo sonographic evaluation of tumor margins during micrographic‐controlled surgery: a promising new tool in dermato‐oncology?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15827
Vancouver
Crisan D, Wortsman X, Alfageme F, Scharffetter-Kochanek K, Crisan M, Bernhard L, et al. In vivo and ex vivo sonographic evaluation of tumor margins during micrographic‐controlled surgery: a promising new tool in dermato‐oncology?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15827
BibTeX
@article{Crisan2025,
author = {Crisan, Diana and Wortsman, Ximena and Alfageme, Fernando and Scharffetter-Kochanek, Karin and Crisan, Maria and Bernhard, Lukas and Tarnowietzki, Evelyne and Schneider, Lars Alexander and Schmid-Wendtner, Monika-H},
title = {In vivo and ex vivo sonographic evaluation of tumor margins during micrographic‐controlled surgery: a promising new tool in dermato‐oncology?},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15827}
}
EUVIMED